FIELD: medicine.
SUBSTANCE: invention refers to a compound of formula to its salt or hydrate where R1 represents hydrogen atom, alkyl group containing 1-6 carbon atoms or cycloalkyl group containing 3-6 carbon atoms; and alkyl group is optionally substituted by halogen atom; R2 represents hydrogen atom or alkyl group containing 1-6 carbon atoms; R3 represents alkyl group containing 1-6 carbon atoms or cycloalkyl group containing 3-6 carbon atoms; and alkyl group is optionally substituted by halogen atom; R4 and R5 independently represent hydrogen atom, halogen atom, alkyl group containing 1-6 carbon atoms, alkoxygroup containing 1-6 carbon atoms or alkenyl group containing 2-6 carbon atoms; and alkyl group is optionally substituted by halogen atom; and provided R4 and R5 are not hydrogen atoms simultaneously; or substitutes R4 and R5 together represent (a) 3-6-members cyclic compound including carbon atom, common for R4 and R5, with formation of a spirocyclic compound with a pyrrolidine ring; or (b) exomethylene group bound with the pyrrolidine ring by a double bond; R6 and R7 independently represent hydrogen atom or alkyl group containing 1-6 carbon atoms; R8 represents halogen-substituted alkyl group containing 1-6 carbon atoms or cycloalkyl group containing 3-6 carbon atoms; and cycloalkyl group can be substituted by halogen atom; R9 represents hydrogen atom; X1 represents hydrogen atom or halogen atom; and A represents nitrogen atom or a fragment presented by formula , where X2 represents hydrogen atom, alkyl group containing 1-6 carbon atoms or alkoxygroup containing 1-6 carbon atoms; or X2 together with R8 represents a cyclic compound containing a portion of a nucleus, and the ring formed thereby optionally contains oxygen atom and is substituted by alkyl group containing 1-6 carbon atoms. Besides, the invention refers to an antibacterial agent based on the compound of formula I, to a therapeutic agent for infections, to a method of treating an infectious disease and an application of said compounds for preparing an antibacterial drug.
EFFECT: there are produced and described new compounds showing strong antibacterial activity in relation to gram-positive and gram-negative bacteria.
30 cl, 112 ex, 10 tbl, 4 dwg
Title | Year | Author | Number |
---|---|---|---|
CONDENSED SUBSTITUTED AMINOPYRROLIDINE DERIVATIVE | 2007 |
|
RU2443698C2 |
AGENT AGAINST ACID-RESISTANT MICROORGANISMS CONTAINING HETEROCYCLIC DERIVATIVES OF BENZOXAZINE AS ACTIVE COMPONENT | 2001 |
|
RU2297420C2 |
DEHALOGENATED COMPOUNDS, ANTIBACTERIAL AGENT AND THERAPEUTIC AGENT BASED ON THEREOF, METHOD FOR PREPARING ANTIBACTERIAL OR MEDICINAL AGENT, USING DEHALOGENATED COMPOUNDS FOR PREPARING ANTIBACTERIAL OR MEDICINAL AGENT | 2001 |
|
RU2298006C2 |
DIPEPTIDYL PEPTIDASE-IV INHIBITORS | 2010 |
|
RU2574410C2 |
BICYCLIC DERIVATIVES OF 1,4-DIHYDRO-4-OXOQUINOLINE-3-CARBOXYLIC ACID OR THEIR SALTS AND PHARMACEUTICAL COMPOSITION SHOWING ANTIBACTERIAL ACTIVITY | 1993 |
|
RU2125046C1 |
PYRIDONE CARBOXYLIC ACID DERIVATIVES AND COMPOSITION BASED ON THEREOF | 1993 |
|
RU2100351C1 |
PRODRUG OF THE AMINO ACID DERIVATIVE | 2017 |
|
RU2739318C2 |
SPIROCOMPOUND OR SALTS THEREOF, METHOD OF PREPARATION THEREOF, AND PHARMACEUTICAL COMPOSITION BASED THEREON HAVING ANTIMICROBIAL ACTIVITY | 1989 |
|
RU2094432C1 |
AZABICYCLIC AND DIAZEPINE DERIVATIVES FOR THE TREATMENT OF OPHTHALMIC DISORDERS | 2018 |
|
RU2795521C2 |
PYRIDO[3,4-D]PYRIMIDINE DERIVATIVE AND ITS PHARMACEUTICALLY ACCEPTABLE SALT | 2017 |
|
RU2796400C2 |
Authors
Dates
2011-06-10—Published
2006-05-19—Filed